US HB6885 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Republican 4-0)
Status: Introduced on May 15 2020 - 25% progression, died in committee
Action: 2020-05-15 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 15 2020 - 25% progression, died in committee
Action: 2020-05-15 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the importation of a drug or device that was manufactured at a banned foreign facility, to create incentives for pharmaceutical or device companies to increase manufacturing capacity in the United States, and for other purposes.
Title
Safe and Secure Medicine Supply for Hardworking Americans Act of 2020
Sponsors
Rep. Bill Flores [R-TX] | Rep. Ron Wright [R-TX] | Rep. James Baird [R-IN] | Rep. Tom Tiffany [R-WI] |
History
Date | Chamber | Action |
---|---|---|
2020-05-15 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2020-05-15 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2020-05-15 | House | Introduced in House |
Subjects
Asia
China
Civil actions and liability
Congressional oversight
Drug safety, medical device, and laboratory regulation
Employment and training programs
Government information and archives
Government trust funds
Health
Health information and medical records
India
Manufacturing
Prescription drugs
Tariffs
Trade restrictions
China
Civil actions and liability
Congressional oversight
Drug safety, medical device, and laboratory regulation
Employment and training programs
Government information and archives
Government trust funds
Health
Health information and medical records
India
Manufacturing
Prescription drugs
Tariffs
Trade restrictions
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/house-bill/6885/all-info |
Text | https://www.congress.gov/116/bills/hr6885/BILLS-116hr6885ih.pdf |